Jennifer M. Brannan

2.5k total citations
22 papers, 1.3k citations indexed

About

Jennifer M. Brannan is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Jennifer M. Brannan has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 7 papers in Public Health, Environmental and Occupational Health and 4 papers in Molecular Biology. Recurrent topics in Jennifer M. Brannan's work include Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (8 papers) and Mosquito-borne diseases and control (7 papers). Jennifer M. Brannan is often cited by papers focused on Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (8 papers) and Mosquito-borne diseases and control (7 papers). Jennifer M. Brannan collaborates with scholars based in United States, Belgium and Germany. Jennifer M. Brannan's co-authors include Qinfen Zhang, Xuekui Yu, Guo‐Qiang Bi, Z. Hong Zhou, Stan Schein, P. Ge, Xiaokang Zhang, John M. Dye, Russell R. Bakken and B. Nebiyou Bekele and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Immunology.

In The Last Decade

Jennifer M. Brannan

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer M. Brannan United States 16 789 429 330 273 109 22 1.3k
Ron Geller Spain 18 592 0.8× 171 0.4× 803 2.4× 244 0.9× 116 1.1× 46 1.6k
Krishna P. Kota United States 21 519 0.7× 185 0.4× 379 1.1× 245 0.9× 60 0.6× 45 1.1k
Isabelle Staropoli France 21 771 1.0× 402 0.9× 466 1.4× 284 1.0× 32 0.3× 37 2.0k
Stéphane Pêtres France 22 380 0.5× 610 1.4× 593 1.8× 190 0.7× 38 0.3× 34 1.5k
Manjula Kalia India 20 660 0.8× 510 1.2× 461 1.4× 362 1.3× 15 0.1× 43 1.6k
Mary A. Rodgers United States 20 522 0.7× 410 1.0× 902 2.7× 582 2.1× 59 0.5× 58 2.2k
Laurent Chatel‐Chaix Canada 23 747 0.9× 870 2.0× 828 2.5× 411 1.5× 20 0.2× 39 2.1k
Christina L. Gardner United States 23 1.1k 1.4× 1.1k 2.5× 387 1.2× 249 0.9× 27 0.2× 42 1.8k
Alexander Rouvinski Israel 14 1.1k 1.4× 1.3k 3.0× 298 0.9× 437 1.6× 19 0.2× 22 1.7k
Simon Delagrave United States 17 281 0.4× 212 0.5× 426 1.3× 315 1.2× 43 0.4× 31 1.1k

Countries citing papers authored by Jennifer M. Brannan

Since Specialization
Citations

This map shows the geographic impact of Jennifer M. Brannan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer M. Brannan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer M. Brannan more than expected).

Fields of papers citing papers by Jennifer M. Brannan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer M. Brannan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer M. Brannan. The network helps show where Jennifer M. Brannan may publish in the future.

Co-authorship network of co-authors of Jennifer M. Brannan

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer M. Brannan. A scholar is included among the top collaborators of Jennifer M. Brannan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer M. Brannan. Jennifer M. Brannan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amiar, Souad, Laura I. Prugar, Kathleen E. Huie, et al.. (2022). Phosphatidylserine clustering by the Ebola virus matrix protein is a critical step in viral budding. EMBO Reports. 23(11). e51709–e51709. 20 indexed citations
2.
Beitzel, Brett, Sheli R. Radoshitzky, Nicholas Di Paola, et al.. (2021). On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization. Viruses. 13(10). 2010–2010.
3.
Wang, Yimeng, Katie A. Howell, Jennifer M. Brannan, et al.. (2021). Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization. Journal of Virology. 95(8). 5 indexed citations
4.
Pu, Szu‐Yuan, Stanford Schor, Sirle Saul, et al.. (2020). BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals. Antiviral Research. 184. 104966–104966. 12 indexed citations
5.
Brannan, Jennifer M., Shihua He, Katie A. Howell, et al.. (2019). Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates. Nature Communications. 10(1). 105–105. 44 indexed citations
6.
Pu, Szu‐Yuan, F.J. Sorrell, Jonathan M. Elkins, et al.. (2019). Synthesis and Structure–Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3-b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity. Journal of Medicinal Chemistry. 62(12). 5810–5831. 42 indexed citations
7.
Froude, Jeffrey W., Andrew S. Herbert, Thibaut Pelat, et al.. (2018). Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail. Viruses. 10(6). 286–286. 16 indexed citations
8.
Dorosky, Danielle E., Laura I. Prugar, Cecilia M. O’Brien, et al.. (2018). AAK1 and GAK inhibitors demonstrate activity against Filoviruses. The Journal of Immunology. 200(Supplement_1). 50.7–50.7. 2 indexed citations
9.
Liu, Jun, Travis K. Warren, Candace D. Blancett, et al.. (2018). Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors. Cell Host & Microbe. 24(3). 405–416.e3. 61 indexed citations
10.
Howell, Katie A., Jennifer M. Brannan, Christopher Bryan, et al.. (2017). Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus. Cell Reports. 19(2). 413–424. 53 indexed citations
11.
Dye, John M. & Jennifer M. Brannan. (2017). Selective AAK1 and GAK Inhibitors for Combating Dengue and Other Emerging Viral Infections. 1 indexed citations
12.
Bekerman, Elena, Grégory Neveu, Ana Shulla, et al.. (2017). Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. Journal of Clinical Investigation. 127(4). 1338–1352. 172 indexed citations
13.
Brannan, Jennifer M., Laura I. Prugar, Russell R. Bakken, et al.. (2015). Interferon α/β Receptor–Deficient Mice as a Model for Ebola Virus Disease. The Journal of Infectious Diseases. 212(suppl 2). S282–S294. 47 indexed citations
14.
Kwilas, Steven A., Ana I. Kuehne, Jennifer M. Brannan, et al.. (2015). Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses. PLoS ONE. 10(9). e0137786–e0137786. 19 indexed citations
15.
Johansen, Lisa M., Jennifer M. Brannan, Sue E. Delos, et al.. (2013). FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection. Science Translational Medicine. 5(190). 190ra79–190ra79. 249 indexed citations
16.
Zhang, Xiaokang, P. Ge, Xuekui Yu, et al.. (2012). Cryo-EM structure of the mature dengue virus at 3.5-Å resolution. Nature Structural & Molecular Biology. 20(1). 105–110. 330 indexed citations
17.
Friedrich, Brian, Corinne Scully, & Jennifer M. Brannan. (2011). Assessment of High-Throughput Screening (HTS) Methods for High-Consequence Pathogens. 2(S3). 1 indexed citations
18.
Brannan, Jennifer M., Wenli Dong, Ludmila Prudkin, et al.. (2009). Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non–Small Cell Lung Cancer. Clinical Cancer Research. 15(13). 4423–4430. 89 indexed citations
19.
Brannan, Jennifer M., Banibrata Sen, Babita Saigal, et al.. (2009). EphA2 in the Early Pathogenesis and Progression of Non–Small Cell Lung Cancer. Cancer Prevention Research. 2(12). 1039–1049. 68 indexed citations
20.
Cheng, Lingpeng, Qinfen Zhang, WeiYu Lin, et al.. (2003). Genetic, biochemical, and structural characterization of a new densovirus isolated from a chronically infected Aedes albopictus C6/36 cell line. Virology. 318(1). 123–133. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ron Geller Breakdown of academic impact, for papers by Krishna P. Kota Breakdown of academic impact, for papers by Isabelle Staropoli Breakdown of academic impact, for papers by Stéphane Pêtres Breakdown of academic impact, for papers by Manjula Kalia Breakdown of academic impact, for papers by Mary A. Rodgers Breakdown of academic impact, for papers by Laurent Chatel‐Chaix Breakdown of academic impact, for papers by Christina L. Gardner Breakdown of academic impact, for papers by Alexander Rouvinski Breakdown of academic impact, for papers by Simon Delagrave
Rankless by CCL
2026